Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Anamorelin Hydrochloride
1. 249921-19-5
2. Anamorelin [inn]
3. Rc 1291
4. Rc-1291
5. Dd5rba1nkf
6. Ono-7643
7. St-1291
8. 3-piperidinecarboxylic Acid, 1-[(2r)-2-[(2-amino-2-methyl-1-oxopropyl)amino]-3-(1h-indol-3-yl)-1-oxopropyl]-3-(phenylmethyl)-, 1,2,2-trimethylhydrazide, (3r)-
9. 2-amino-n-[(2r)-1-[(3r)-3-benzyl-3-[dimethylamino(methyl)carbamoyl]piperidin-1-yl]-3-(1h-indol-3-yl)-1-oxopropan-2-yl]-2-methylpropanamide
10. 3-piperidinecarboxylic Acid, 1-(2-methylalanyl-d-tryptophyl)-3-(phenylmethyl)-, Trimethylhydrazide, (3r)-
11. Unii-dd5rba1nkf
12. Anamorelin [mi]
13. Ono-7643;anamorelin
14. Anamorelin [who-dd]
15. Schembl935751
16. Chembl2110579
17. Dtxsid20179702
18. Ex-a154
19. Bcp06108
20. Mfcd11973671
21. Ono-7643rc-1291
22. S4980
23. Zinc43130908
24. Akos030526752
25. Ccg-269985
26. Db06645
27. Ncgc00378854-01
28. Ac-33703
29. As-75284
30. Hy-14734
31. 921a195
32. Q20707542
33. (3r)-1-((2r)-2-((2-amino-2-methylpropanoyl)amino)-3-(indol-3-yl)propanoyl)-3-benzyl-n,n',n'-trimethylpiperidine-3-carbohydrazide
34. 2-amino-n-[(2r)-1-[(3r)-3-benzyl-3-(n,n',n'-trimethylhydrazinecarbonyl)piperidin-1-yl]-3-(1h-indol-3-yl)-1-oxopropan-2-yl]-2-methylpropanamide
| Molecular Weight | 546.7 g/mol |
|---|---|
| Molecular Formula | C31H42N6O3 |
| XLogP3 | 2.8 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 9 |
| Exact Mass | 546.33183922 g/mol |
| Monoisotopic Mass | 546.33183922 g/mol |
| Topological Polar Surface Area | 115 Ų |
| Heavy Atom Count | 40 |
| Formal Charge | 0 |
| Complexity | 904 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Investigated for use/treatment in cachexia and anorexia.
Treatment of anorexia, cachexia or unintended weight loss in adult patients with non-small cell lung cancer (NSCLC)
V03
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Anamorelin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Anamorelin, including repackagers and relabelers. The FDA regulates Anamorelin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Anamorelin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Anamorelin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Anamorelin supplier is an individual or a company that provides Anamorelin active pharmaceutical ingredient (API) or Anamorelin finished formulations upon request. The Anamorelin suppliers may include Anamorelin API manufacturers, exporters, distributors and traders.
click here to find a list of Anamorelin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Anamorelin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Anamorelin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Anamorelin GMP manufacturer or Anamorelin GMP API supplier for your needs.
A Anamorelin CoA (Certificate of Analysis) is a formal document that attests to Anamorelin's compliance with Anamorelin specifications and serves as a tool for batch-level quality control.
Anamorelin CoA mostly includes findings from lab analyses of a specific batch. For each Anamorelin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Anamorelin may be tested according to a variety of international standards, such as European Pharmacopoeia (Anamorelin EP), Anamorelin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Anamorelin USP).
LOOKING FOR A SUPPLIER?
